Showing 281-290 of 328 grants

Title Institution Researcher Program Duration Total Award Amount
Dock2-mediated T cell migration as a targetable shared mechanism in autoimmunity University of Pittsburgh Alok Joglekar Cures 01-September-2025 to 31-August-2026 $149,999.05
MRI of Pancreas Perfusion in Response to Glucose University of Texas at Austin Jack Virostko Cures 01-July-2023 to 30-June-2025 $187,620.00
Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Mitigate Diabetic Ketoacidosis Risk? University of Texas Health Science Center at San Antonio Muhammad Abdul-Ghani Improving Lives 01-June-2019 to 30-September-2025 $1,573,835.31
Optimization of fast-acting venom insulins as therapeutic candidates for T1D University of Utah Helena Safavi Improving Lives 01-September-2022 to 31-August-2026 $890,372.53
Structural approaches to understand biased insulin signaling and design glucose-binding proteins for smart insulin therapeutics University of Utah Amber Vogel Improving Lives 01-March-2024 to 28-February-2027 $228,995.00
Promoting functional maturation of SC-derived beta-cells by novel Epigenetic regulators University of Washington Vincenzino Cirulli Cures 01-October-2024 to 30-September-2026 $500,000.00
microRNAs as regulators of stem cell differentiation into islet cells University of Washington Vincenzino Cirulli Cures 01-August-2025 to 31-July-2027 $600,000.00
A Multi-task Learning Framework for Developing Genetic Risk Score (GRS) Models of T1D for Multi-Ethnic Population University of Washington Shuai Huang Cures 01-August-2022 to 31-August-2025 $300,081.37
Effects of SGLT2 inhibition on early diabetic kidney disease: interrogation of renal energetics by functional imaging and single-cell transcriptomics University of Washington Petter Bjornstad Improving Lives 01-June-2024 to 30-November-2025 $488,511.63
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) University of Washington Petter Bjornstad Improving Lives 01-September-2025 to 31-August-2028 $2,040,014.30